Completed PHASE4 INTERVENTIONAL 1-arm NCT01107067

Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism

Phase IV Study to Investigate the Effect of Testosterone Treatment on Paraoxonase Level in Male Patients With Hypogonadotrophic Hypogonadism

Sponsor: Gulhane School of Medicine

Conditions Hypogonadism

Interventions Sustanon

Updated 5 times since 2017 Last updated: Apr 19, 2010 Started: Jun 30, 2008 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypogonadism, this trial is completed. The trial is conducted by Gulhane School of Medicine and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gulhane School of Medicine

Data source: Gulhane School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)